Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NOVN

Novan (NOVN) Stock Price, News & Analysis

Novan logo

About Novan Stock (NASDAQ:NOVN)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
7.19 million shs
Average Volume
602,421 shs
Market Capitalization
$2.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NOVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novan and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NOVN Stock News Headlines

Buffett, Gates and Bezos Dumping Stocks
The world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated billions of shares. Bill Gates sold 500,000 shares of Microsoft. Jeff Bezos filed to sell Amazon shares worth $4.8 billion. What is going on? One multi-millionaire believes they are preparing for a catastrophic event. But not a crash, bank run, or recession. It’s something we haven’t see in America for more than a century.tc pixel
Novartis AG
Novartis AG Registered Shares
See More Headlines

NOVN Stock Analysis - Frequently Asked Questions

Novan, Inc. (NASDAQ:NOVN) released its earnings results on Monday, May, 15th. The company reported ($0.54) EPS for the quarter, missing the consensus estimate of ($0.32) by $0.22. The company earned $3.17 million during the quarter, compared to analysts' expectations of $6.19 million. Novan had a negative trailing twelve-month return on equity of 700.28% and a negative net margin of 128.61%.
Read the conference call transcript
.

Novan (NOVN) raised $46 million in an IPO on Wednesday, September 21st 2016. The company issued 3,800,000 shares at a price of $11.00-$13.00 per share. Piper Jaffray acted as the underwriter for the IPO and JMP Securities and Wedbush PacGrow were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Novan investors own include Meta Platforms (META), Bionano Genomics (BNGO), Inovio Pharmaceuticals (INO), Tonix Pharmaceuticals (TNXP), NIO (NIO), Tesla (TSLA) and Zomedica (ZOM).

Company Calendar

Last Earnings
5/15/2023
Today
9/17/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:NOVN
CIK
1467154
Employees
90
Year Founded
2008

Profitability

EPS (Trailing Twelve Months)
($1.32)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$31.31 million
Net Margins
-128.61%
Pretax Margin
-128.39%
Return on Equity
-700.28%
Return on Assets
-39.58%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.74
Quick Ratio
0.72

Sales & Book Value

Annual Sales
$24.71 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.19 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
28,015,000
Free Float
27,651,000
Market Cap
$2.64 million
Optionable
Not Optionable
Beta
-0.06

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:NOVN) was last updated on 9/17/2025 by MarketBeat.com Staff
From Our Partners